BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31886314)

  • 1. miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA.
    Yuan S; Tang C; Chen D; Li F; Huang M; Ye J; He Z; Li W; Chen Y; Lin X; Wang X; Cai X
    J Immunol Res; 2019; 2019():9827574. PubMed ID: 31886314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus.
    Xu L; Wang L; Shi Y; Deng Y; Oates JC; Kamen DL; Gilkeson GS; Wang F; Zhang M; Tan W; Tsao BP
    Arthritis Rheumatol; 2022 Mar; 74(3):496-507. PubMed ID: 34569195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of microRNA-448 suppresses CD4
    Zhang J; Guo Y; Sun Y; Chang L; Wang X
    Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
    Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
    Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus.
    Rasmussen TK; Andersen T; Bak RO; Yiu G; Sørensen CM; Stengaard-Pedersen K; Mikkelsen JG; Utz PJ; Holm CK; Deleuran B
    Arthritis Res Ther; 2015 Jun; 17(1):154. PubMed ID: 26055806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
    Sun H; Guo F; Xu L
    J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus.
    El-Akhras BA; Talaat RM; El-Masry SA; Bassyouni IH; El-Sayed IH; Ali YB
    Int J Immunopathol Pharmacol; 2023; 37():3946320231154998. PubMed ID: 36740569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
    Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
    J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-410 Down-Regulates the Expression of Interleukin-10 by Targeting STAT3 in the Pathogenesis of Systemic Lupus Erythematosus.
    Liu D; Zhang N; Zhang X; Qin M; Dong Y; Jin L
    Cell Physiol Biochem; 2016; 39(1):303-15. PubMed ID: 27351906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.
    Tang C; Wang X; Xie Y; Cai X; Yu N; Hu Y; Zheng Z
    Cell Physiol Biochem; 2018; 51(2):979-990. PubMed ID: 30466076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated miR‑29a promotes B cell overactivation by upregulating Crk‑like protein in systemic lupus erythematosus.
    Shi X; Ye L; Xu S; Guo G; Zuo Z; Ye M; Zhu L; Li B; Xue X; Lin Q; Ding X
    Mol Med Rep; 2020 Aug; 22(2):841-849. PubMed ID: 32467986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus.
    Wang X; Zhang C; Wu Z; Chen Y; Shi W
    Arthritis Res Ther; 2018 Jun; 20(1):118. PubMed ID: 29884225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients.
    Lashine YA; Salah S; Aboelenein HR; Abdelaziz AI
    Lupus; 2015 Mar; 24(3):240-7. PubMed ID: 25253569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.
    Guo G; Wang H; Shi X; Ye L; Wu K; Lin K; Ye S; Li B; Zhang H; Lin Q; Ye S; Xue X; Chen C
    J Transl Med; 2018 Dec; 16(1):370. PubMed ID: 30577810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
    Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
    Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
    Li Z; Li Y; Huang L; Xu H; Yu X; Ye R
    Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3.
    Xie M; Wang J; Gong W; Xu H; Pan X; Chen Y; Ru S; Wang H; Chen X; Zhao Y; Li J; Yin Q; Xia S; Zhou X; Liu X; Shao Q
    J Autoimmun; 2019 Aug; 102():96-113. PubMed ID: 31130368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
    Xie L; Xu J
    J Rheumatol; 2018 Oct; 45(10):1397-1405. PubMed ID: 29907673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis.
    Sun KH; Yu CL; Tang SJ; Sun GH
    Immunology; 2000 Mar; 99(3):352-60. PubMed ID: 10712664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-301a-3p Advances IRAK1-Mediated Differentiation of Th17 Cells to Promote the Progression of Systemic Lupus Erythematosus via Targeting PELI1.
    Luo S; Wu R; Li Q; Zhang G
    J Healthc Eng; 2021; 2021():2982924. PubMed ID: 34931135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.